LONDON (Reuters) - Clinical trials of three potential Ebola treatments will begin in December in Guinea and Liberia at medical centres run by Medecins Sans Frontieres, the medical charity said on Thursday.
The separate trials, involving up to several hundred patients, are designed to test the drugs brincidofovir, from the U.S. firm Chimerix, and favipiravir, from Japan's Fujifilm, and to see how well blood plasma taken from Ebola survivors may work in curing those still infected.
Already a subscriber? Log in.
Subscribe to win RM50 Touch 'n Go e-Voucher! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!